rethinkTHC Search
Menu
Study breakdown

The Placenta Actively Pumps THC Away from the Fetus — But Not Completely

Laboratory AnalysisModerate evidence
The takeaway

Human placenta perfusion studies confirm that P-glycoprotein and BCRP transporters actively pump THC back toward the mother, partially protecting the fetus from cannabis exposure — but some THC still gets through.

Pregnant cannabis users, OB-GYNs, placental biologists, and pharmacologists studying drug-transporter interactions

What the researchers found

A cocktail of P-gp and BCRP inhibitors significantly increased maternal-to-fetal THC transfer in perfused human placentas, confirming these transporters actively efflux THC and partially limit fetal exposure.

Why it matters

Understanding how the placenta handles THC explains why fetal exposure occurs but is limited — and why factors that compromise placental transporter function could increase fetal vulnerability.

The numbers in context

Inhibitor cocktail significantly increased unbound maternal-to-fetal THC clearance index compared to uninhibited controls; previous single-inhibitor (valspodar) failed to block efflux due to multiple transporter binding sites.

How the study worked

Ex vivo human placenta cotyledon perfusion with THC in the absence and presence of a cocktail of P-gp and BCRP inhibitors, measuring unbound maternal-to-fetal THC clearance index.

What this study cannot tell us

Ex vivo perfusion model has limited duration; does not capture chronic exposure effects; individual variation in transporter expression not assessed; does not measure THC metabolite transfer.

How to read the evidence

Direct human tissue experimentation with appropriate controls and building on prior work, but ex vivo model has inherent limitations.

When this study was published

Published in 2026, advancing understanding of placental THC handling with clinical implications.

The bigger picture

This reveals the placenta as an active gatekeeper against THC — but one that can be overwhelmed by high doses, genetic variants, or drug interactions that impair P-gp/BCRP function.

Questions still open

  • Do genetic variations in P-gp/BCRP affect fetal THC exposure? Could medications that inhibit these transporters inadvertently increase fetal cannabis exposure?

Common questions

Does the placenta protect the baby from THC?
Partially — the placenta has active pump proteins (P-gp and BCRP) that push THC back toward the mother, but they don't completely prevent fetal exposure.
Can anything affect how much THC reaches the fetus?
Yes — medications, genetic variations, or conditions that impair the placental transporters could increase THC transfer to the fetus, potentially increasing risk.

Read the original research

Elucidating the role of ABC transporters in the placental efflux of (-)- Δ9-tetrahydrocannabinol (THC) using a cocktail of ABC transport inhibitors.

Placenta, 174, 174-177

Citation

Balhara, Ankit; Chen, Xin; Kumar, Aditya R; Wasickanin, Morgan E; Monson, Joshua W; Damicis, Jennifer R; Kinsman, Hillary J; Ieronimakis, Nicholas; Unadkat, Jashvant D. (2026). Elucidating the role of ABC transporters in the placental efflux of (-)- Δ9-tetrahydrocannabinol (THC) using a cocktail of ABC transport inhibitors.. Placenta, 174, 174-177. https://doi.org/10.1016/j.placenta.2025.12.012

Explore the wider topic